Search Results for: Marc Tessier-Lavigne
The annual recipient of the NY/NJ CEO Lifetime Achievement Award is nominated and elected by peers from within the biotechnology industry and it recognizes the extraordinary contributions of the awardees toward advancing medical science and products that address unmet medical needs, as well as in helping to create an environment that fosters the growth of the industry in the New York metropolitan area.
Congress of the United States U.S. House of Representatives Committee on Science, Space, and Technology Subcommittee on Research and Technology “Policies to Spur Innovative Medical Breakthroughs from Laboratories to Patients” Written Testimony of Dr. Marc Tessier-Lavigne Rayburn House Office Building … More »
Medical innovation requires federal support and structural improvements, Marc Tessier-Lavigne tells members of Congress
Speaking at a hearing on public versus private contributions to medical breakthroughs, Rockefeller’s president explained the ecosystem responsible for taking a biological insight on, for example, how tumors spread, and turning it into a treatment that improves or saves lives. He also offered suggestions for how the federal government could further encourage such breakthroughs.
Tessier-Lavigne, Rockefeller president and head of the Laboratory of Brain Development, and Jeffrey M. Friedman head of the Laboratory of Molecular Genetics, were elected to the honorary society and independent policy research center along with 198 other leaders in science, art, academia and the civic, corporate and philanthropic arenas. The current membership includes some 250 Nobel laureates and more than 60 Pulitzer Prize winners, and 23 other Rockefeller University faculty members are fellows.
President Marc Tessier-Lavigne will receive the Henry G. Friesen International Prize in Health Research, established by the Friends of Canadian Institutes of Health Research in collaboration with the Canadian Academy of Health Sciences to recognize exceptional innovation by a visionary health leader of international stature.
A world leader in the study of brain development, Tessier-Lavigne has pioneered the identification of the molecules that direct the formation of connections among nerve cells to establish neuronal circuits in the mammalian brain and spinal cord. Tessier-Lavigne is among 65 new members and five foreign associates elected to the Institute this year. More »
Rockefeller University’s President will receive the Memorial Sloan-Kettering Medal for Outstanding Contributions to Biomedical Research at MSKCC’s 2011 Academic Convocation. More »
Marc Tessier-Lavigne, a leading neuroscientist and the former chief scientific officer of Genentech, takes over as president of The Rockefeller University today, replacing Paul Nurse, who has left to become president of the Royal Society in London. More »
The university’s Board of Trustees has elected Tessier-Lavigne to succeed Paul Nurse on March 11, 2011. A leader in the study of brain development, he is currently executive vice president for research and chief scientific officer at Genentech, one the world’s leading biotech companies. More »
Marc Tessier-Lavigne, Ph.D., will step down from his position as president of The Rockefeller University September 1, 2016, to become the 11th president of Stanford University, it was announced today. More »
Will We Find a Cure for Cancer and Alzheimer’s Anytime Soon? “Science is on the march in the heart of New York City. With five Nobel Laureates on its faculty, Rockefeller University scientists are working to unlock the mysteries … More »
Genentech Brain Trust Leaves With $217 Million For New Startup To Fight Alzheimer’s And Parkinson’s “Three former top researchers at Genentech, the legendary biotech that is now part of Roche Holding, have raised $217 million in venture capital to … More »
The award recognizes Fuchs’s contributions to our understanding of skin biology and skin stem cells, including discoveries that have led to advancements in treating skin cancer and severe burns.
In addition to serving as host for a life sciences roundtable, Rockefeller president Marc Tessier-Lavigne led mayor de Blasio on a tour of the campus, introduced him to members of his laboratory, and outlined plans for the new Stavros Niarchos Foundation–David Rockefeller River Campus. More »
Luciano Marraffini, among the first scientists to plumb the workings of the CRISPR-Cas system, is promoted to associate professor
Luciano Marraffini is exploring an immune response used by bacteria to defend against viruses. His work is mainly focused on understanding the basic biology and evolution of microorganisms, but it also has implications for the development of gene-editing technologies. More »
Scientists have long believed axons regulate their own pruning during development. But recent findings have challenged this assumption, and now scientists have proven that axons receive instructions from the cell body when its time to degenerate.
The immune system must protect against potential infections, but over-vigilant reactions can cause problems. New research from Rockefeller shows that neurons in the intestine send signals to immune cells to curb inflammation. More »
The university has started to refurbish the damaged seawall that supports the East River Esplanade between 63rd and 68th Streets as part of the campus extension project. The esplanade will also be improved, with a new bike lane, landscaping, and a noise barrier along the FDR Drive. More »